Table of Content

1 Industry Overview

• 1.1 Duchenne Muscular Dystrophy Industry

Figure Duchenne Muscular Dystrophy Industry Chain Structure

• 1.1.1 Overview
• 1.1.2 Development of Duchenne Muscular Dystrophy

Table Upstream Segment of Duchenne Muscular Dystrophy

• 1.2.2 Downstream

Table Application Segment of Duchenne Muscular Dystrophy

Table Global Duchenne Muscular Dystrophy Market 2015-2025, by Application, in USD Million

• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Duchenne Muscular Dystrophy Market by Type

• 3.1 By Type
  • 3.1.1 Deflazacort

Table Major Company List of Deflazacort

• 3.1.2 Prednisone

Table Major Company List of Prednisone

• 3.1.3 Others

Table Major Company List of Others

• 3.2 Market Size

Table Global Duchenne Muscular Dystrophy Market 2015-2019, by Type, in USD Million

Figure Global Duchenne Muscular Dystrophy Market Growth 2015-2019, by Type, in USD Million

Table Global Duchenne Muscular Dystrophy Market 2015-2019, by Type, in Volume

Figure Global Duchenne Muscular Dystrophy Market Growth 2015-2019, by Type, in Volume

• 3.3 Market Forecast

Table Global Duchenne Muscular Dystrophy Market Forecast 2020-2025, by Type, in USD Million

Table Global Duchenne Muscular Dystrophy Market Forecast 2020-2025, by Type, in Volume

4 Major Companies List

• 4.1 PTC Therapeutics (Company Profile, Sales Data etc.)
  • 4.1.1 PTC Therapeutics Profile

Table PTC Therapeutics Overview List

• 4.1.2 PTC Therapeutics Products & Services
• 4.1.3 PTC Therapeutics Business Operation Conditions

Table Business Operation of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.2 Sarepta Therapeutics (Company Profile, Sales Data etc.)
  • 4.2.1 Sarepta Therapeutics Profile

Table Sarepta Therapeutics Overview List

• 4.2.2 Sarepta Therapeutics Products & Services
• 4.2.3 Sarepta Therapeutics Business Operation Conditions

Table Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.3 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
  • 4.3.1 Bristol-Myers Squibb Profile

Table Bristol-Myers Squibb Overview List

• 4.3.2 Bristol-Myers Squibb Products & Services
• 4.3.3 Bristol-Myers Squibb Business Operation Conditions

Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.4 ITALFARMACO (Company Profile, Sales Data etc.)
  • 4.4.1 ITALFARMACO Profile

Table ITALFARMACO Overview List

• 4.4.2 ITALFARMACO Products & Services
• 4.4.3 ITALFARMACO Business Operation Conditions

Table Business Operation of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.5 BioMarin (Company Profile, Sales Data etc.)
  • 4.5.1 BioMarin Profile

Table BioMarin Overview List

• 4.5.2 BioMarin Products & Services
• 4.5.3 BioMarin Business Operation Conditions

Table Business Operation of BioMarin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.6 Daiichi Sankyo (Company Profile, Sales Data etc.)
  • 4.6.1 Daiichi Sankyo Profile

Table Daiichi Sankyo Overview List

• 4.6.2 Daiichi Sankyo Products & Services
• 4.6.3 Daiichi Sankyo Business Operation Conditions

Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.7 Solid Biosciences (Company Profile, Sales Data etc.)
  • 4.7.1 Solid Biosciences Profile

Table Solid Biosciences Overview List

• 4.7.2 Solid Biosciences Products & Services
• 4.7.3 Solid Biosciences Business Operation Conditions

Table Business Operation of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.8 Summit Therapeutics (Company Profile, Sales Data etc.)
  • 4.8.1 Summit Therapeutics Profile

Table Summit Therapeutics Overview List

• 4.8.2 Summit Therapeutics Products & Services
• 4.8.3 Summit Therapeutics Business Operation Conditions

Table Business Operation of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.9 FibroGen (Company Profile, Sales Data etc.)
  • 4.9.1 FibroGen Profile

Table FibroGen Overview List

• 4.9.2 FibroGen Products & Services
• 4.9.3 FibroGen Business Operation Conditions

Table Business Operation of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.10 NS Pharma (Company Profile, Sales Data etc.)
  • 4.10.1 NS Pharma Profile

Table NS Pharma Overview List

• 4.10.2 NS Pharma Products & Services
• 4.10.3 NS Pharma Business Operation Conditions

Table Business Operation of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.11 Pfizer (Company Profile, Sales Data etc.)
  • 4.11.1 Pfizer Profile

Table Pfizer Overview List

• 4.11.2 Pfizer Products & Services
• 4.11.3 Pfizer Business Operation Conditions

Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.12 ReveraGen BioPharma (Company Profile, Sales Data etc.)
  • 4.12.1 ReveraGen BioPharma Profile

Table ReveraGen BioPharma Overview List

• 4.12.2 ReveraGen BioPharma Products & Services
• 4.12.3 ReveraGen BioPharma Business Operation Conditions

Table Business Operation of ReveraGen BioPharma (Sales Revenue, Cost, Gross Margin)

• 4.13 Wave Life (Company Profile, Sales Data etc.)
  • 4.13.1 Wave Life Profile

Table Wave Life Overview List

• 4.13.2 Wave Life Products & Services
• 4.13.3 Wave Life Business Operation Conditions

Table Business Operation of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 4.14 Genethon (Company Profile, Sales Data etc.)
  • 4.14.1 Genethon Profile

Table Genethon Overview List

• 4.14.2 Genethon Products & Services
• 4.14.3 Genethon Business Operation Conditions

Table Business Operation of Genethon (Sales Revenue, Cost, Gross Margin)

• 4.15 Santhera Pharmaceuticals (Company Profile, Sales Data etc.)
  • 4.15.1 Santhera Pharmaceuticals Profile

Table Santhera Pharmaceuticals Overview List

• 4.15.2 Santhera Pharmaceuticals Products & Services
• 4.15.3 Santhera Pharmaceuticals Business Operation Conditions

Table Business Operation of Santhera Pharmaceuticals (Sales Revenue, Cost, Gross Margin)

5 Market Competition

• 5.1 Company Competition

Table Global Duchenne Muscular Dystrophy Sales Revenue 2015-2019, by Company, in USD Million

Table Global Duchenne Muscular Dystrophy Sales Revenue Share 2015-2019, by Company, in USD Million

Figure Global Duchenne Muscular Dystrophy Sales Revenue Share in 2019, by Company, in USD Million

Table Global Duchenne Muscular Dystrophy Sales Volume 2015-2019, by Company, in Volume

Table Global Duchenne Muscular Dystrophy Sales Volume Share 2015-2019, by Company, in Volume

Figure Global Duchenne Muscular Dystrophy Sales Volume Share in 2019, by Company, in Volume

• 5.2 Regional Market by Company

Figure North America Duchenne Muscular Dystrophy Market Concentration, in 2019

Figure Europe Duchenne Muscular Dystrophy Market Market Concentration, in 2019

Figure Asia-Pacific Duchenne Muscular Dystrophy MMarket Concentration, in 2019

Figure South America Duchenne Muscular Dystrophy Market Concentration, in 2019

Figure Middle East & Africa Duchenne Muscular Dystrophy Market Concentration, in 2019

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Male

Figure Duchenne Muscular Dystrophy Demand in Male, 2015-2019, in USD Million

Figure Duchenne Muscular Dystrophy Demand in Male, 2015-2019, in Volume

• 6.1.2 Demand in Female

Figure Duchenne Muscular Dystrophy Demand in Female, 2015-2019, in USD Million

Figure Duchenne Muscular Dystrophy Demand in Female, 2015-2019, in Volume

• 6.2 Regional Demand Comparison

Table Regional Demand Comparison List

Table Major Application in Different Regions

• 6.3 Demand Forecast

Table Duchenne Muscular Dystrophy Demand Forecast 2020-2025, by Application, in USD Million

Figure Duchenne Muscular Dystrophy Market Growth 2020-2025, by Application, in USD Million

Figure Duchenne Muscular Dystrophy Market Share in 2025, by Application, in USD Million

Table Duchenne Muscular Dystrophy Demand Forecast 2020-2025, by Application, in Volume

Table Duchenne Muscular Dystrophy Market Growth 2020-2025, by Application, in Volume

Table Duchenne Muscular Dystrophy Market Share in 2025, by Application, in Volume

7 Region Operation

• 7.1 Regional Production

Table Duchenne Muscular Dystrophy Production 2015-2019, by Region, in USD Million

Table Duchenne Muscular Dystrophy Production 2015-2019, by Region, in Volume

• 7.2 Regional Market

Table Global Duchenne Muscular Dystrophy Market 2015-2019, by Region, in USD Million

Table Global Duchenne Muscular Dystrophy Market Share 2015-2019, by Region, in USD Million

Table Global Duchenne Muscular Dystrophy Market 2015-2019, by Region, in Volume

Table Global Duchenne Muscular Dystrophy Market Share 2015-2019, by Region, in Volume

• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview

  Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in USD Million

  Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in Volume

  • 7.3.1.2 by Country (U.S., Canada, Mexico)

Table North America Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in USD Million

Table North America Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in Volume

• 7.3.2 Europe
  • 7.3.2.1 Overview

Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in USD Million

Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in Volume

• 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

Table Europe Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in USD Million

Table Europe Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in Volume

• 7.3.3 Asia-Pacific
  • 7.3.3.1 Overview

Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in USD Million

Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in Volume

• 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in USD Million

Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in Volume

• 7.3.4 South America
  • 7.3.4.1 Overview

Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in USD Million

Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in Volume

• 7.3.4.2 by Country (Brazil, Argentina etc.)

Table South America Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in USD Million

Table South America Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in Volume

• 7.3.5 Middle East & Africa
  • 7.3.5.1 Overview

Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in USD Million

Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in Volume

• 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in USD Million

Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in Volume

• 7.4 Regional Import & Export
• 7.5 Regional Forecast

Table Duchenne Muscular Dystrophy Market Forecast 2020-2025, by Region, in USD Million

Table Duchenne Muscular Dystrophy Market Forecast 2020-2025, by Region, in Volume

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change

Table Price Factors List

• 8.1.3 Manufacturers Gross Margin Analysis

Figure Marketing Channels Overview

9 Research Conclusion

List of Tables

List of Table

List of Table

Table Upstream Segment of Duchenne Muscular Dystrophy

Table Application Segment of Duchenne Muscular Dystrophy

Table Global Duchenne Muscular Dystrophy Market 2015-2025, by Application, in USD Million

Table Major Company List of Prednisone

Table Major Company List of Others

Table Global Duchenne Muscular Dystrophy Market 2015-2019, by Type, in USD Million

Table Global Duchenne Muscular Dystrophy Market 2015-2019, by Type, in Volume

Table Global Duchenne Muscular Dystrophy Market Forecast 2020-2025, by Type, in USD Million

Table Global Duchenne Muscular Dystrophy Market Forecast 2020-2025, by Type, in Volume

Table PTC Therapeutics Overview List

Table Business Operation of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sarepta Therapeutics Overview List

Table Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Overview List

Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table ITALFARMACO Overview List

Table Business Operation of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table BioMarin Overview List

Table Business Operation of BioMarin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Daiichi Sankyo Overview List

Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Solid Biosciences Overview List

Table Business Operation of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Summit Therapeutics Overview List

Table Business Operation of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table FibroGen Overview List

Table Business Operation of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table NS Pharma Overview List

Table Business Operation of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table ReveraGen BioPharma Overview List

Table Business Operation of ReveraGen BioPharma (Sales Revenue, Cost, Gross Margin)

Table Wave Life Overview List

Table Business Operation of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Genethon Overview List

Table Business Operation of Genethon (Sales Revenue, Cost, Gross Margin)

Table Santhera Pharmaceuticals Overview List

Table Business Operation of Santhera Pharmaceuticals (Sales Revenue, Cost, Gross Margin)

Table Global Duchenne Muscular Dystrophy Sales Revenue 2015-2019, by Company, in USD Million

Table Global Duchenne Muscular Dystrophy Sales Revenue Share 2015-2019, by Company, in USD Million

Table Global Duchenne Muscular Dystrophy Sales Volume 2015-2019, by Company, in Volume

Table Global Duchenne Muscular Dystrophy Sales Volume Share 2015-2019, by Company, in Volume

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Duchenne Muscular Dystrophy Demand Forecast 2020-2025, by Application, in USD Million

Table Duchenne Muscular Dystrophy Demand Forecast 2020-2025, by Application, in Volume

Table Duchenne Muscular Dystrophy Market Growth 2020-2025, by Application, in Volume

Table Duchenne Muscular Dystrophy Market Share in 2025, by Application, in Volume

Table Duchenne Muscular Dystrophy Production 2015-2019, by Region, in USD Million

Table Duchenne Muscular Dystrophy Production 2015-2019, by Region, in Volume

Table Global Duchenne Muscular Dystrophy Market 2015-2019, by Region, in USD Million

Table Global Duchenne Muscular Dystrophy Market Share 2015-2019, by Region, in USD Million

Table Global Duchenne Muscular Dystrophy Market 2015-2019, by Region, in Volume

Table Global Duchenne Muscular Dystrophy Market Share 2015-2019, by Region, in Volume

Table North America Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in USD Million

Table North America Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in Volume

Table Europe Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in USD Million

Table Europe Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in Volume

Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in USD Million

Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in Volume

Table South America Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in USD Million

Table South America Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in Volume

Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in USD Million

Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2015-2019, by Country, in Volume

Table Duchenne Muscular Dystrophy Market Forecast 2020-2025, by Region, in USD Million

Table Duchenne Muscular Dystrophy Market Forecast 2020-2025, by Region, in Volume

Table Price Factors List

List of Figures

List of Figure

Figure Duchenne Muscular Dystrophy Industry Chain Structure

Figure Global Duchenne Muscular Dystrophy Market Growth 2015-2019, by Type, in USD Million

Figure Global Duchenne Muscular Dystrophy Market Growth 2015-2019, by Type, in Volume

Figure Global Duchenne Muscular Dystrophy Sales Revenue Share in 2019, by Company, in USD Million

Figure Global Duchenne Muscular Dystrophy Sales Volume Share in 2019, by Company, in Volume

Figure North America Duchenne Muscular Dystrophy Market Concentration, in 2019

Figure Europe Duchenne Muscular Dystrophy Market Market Concentration, in 2019

Figure Asia-Pacific Duchenne Muscular Dystrophy MMarket Concentration, in 2019

Figure South America Duchenne Muscular Dystrophy Market Concentration, in 2019

Figure Middle East & Africa Duchenne Muscular Dystrophy Market Concentration, in 2019

Figure Duchenne Muscular Dystrophy Demand in Male, 2015-2019, in USD Million

Figure Duchenne Muscular Dystrophy Demand in Male, 2015-2019, in Volume

Figure Duchenne Muscular Dystrophy Demand in Female, 2015-2019, in USD Million

Figure Duchenne Muscular Dystrophy Demand in Female, 2015-2019, in Volume

Figure Duchenne Muscular Dystrophy Market Growth 2020-2025, by Application, in USD Million

Figure Duchenne Muscular Dystrophy Market Share in 2025, by Application, in USD Million

Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in USD Million

Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in Volume

Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in USD Million

Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in Volume

Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in USD Million

Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in Volume

Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in USD Million

Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in Volume

Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in USD Million

Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2015-2019, in Volume

Figure Marketing Channels Overview

Snapshot
Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The global Duchenne Muscular Dystrophy market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Duchenne Muscular Dystrophy by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Deflazacort
Prednisone
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
PTC Therapeutics
Sarepta Therapeutics
Bristol-Myers Squibb
ITALFARMACO
BioMarin
Daiichi Sankyo
Solid Biosciences
Summit Therapeutics
FibroGen
NS Pharma
Pfizer
ReveraGen BioPharma
Wave Life
Genethon
Santhera Pharmaceuticals
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Male
Female
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)